Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Alcon Inc (ALC)

Alcon Inc (ALC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alcon Inc Rue Louis-d`Affry 6 Fribourg V8 1701 CHE

www.alcon.com Employees: 25,599 P: 817-293-0450

Sector:

Medical

Description:

Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.

Key Statistics

Overview:

Market Capitalization, $K 38,965,960
Enterprise Value, $K 41,932,960
Shares Outstanding, K 493,240
Float, K 485,743
% Float 98.48%
Short Interest, K 6,951
Short Float 1.41%
Days to Cover 7.35
Short Volume Ratio 0.37
% of Insider Shareholders 1.52%
% of Institutional Shareholders 53.86%

Financials:

Annual Sales, $ 9,911 M
Annual Net Income, $ 1,018 M
Last Quarter Sales, $ 2,614 M
Last Quarter Net Income, $ 237,000 K
EBIT, $ 1,442 M
EBITDA, $ 2,668 M

Growth:

1-Year Return -6.29%
3-Year Return 5.70%
5-Year Return 10.25%
5-Year Revenue Growth 32.01%
5-Year Earnings Growth 61.38%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.79 on 11/11/25
Next Earnings Date 02/24/26
Earnings Per Share ttm 3.00
EPS Growth vs. Prev Qtr 3.95%
EPS Growth vs. Prev Year -2.47%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payable Date 06/15/12
Dividend Payout Ratio 0.00%

ALC Ratios

Ratio
Price/Earnings ttm 26.56
Price/Earnings forward 23.47
Price/Earnings to Growth 3.80
Return-on-Equity % 6.83%
Return-on-Assets % 4.82%
Profit Margin % 10.27%
Debt/Equity 0.21
Price/Sales 3.86
Price/Cash Flow 14.26
Price/Book 1.77
Book Value/Share 44.78
Interest Coverage 7.54
60-Month Beta 0.97
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar